Jane Davies

Early life and education Davies studied medicine at the University of Dundee. She graduated in 1987, and began paediatric training in London.

Career and research Davies joined the National Heart and Lung Institute in 1999, where she has specialised in cystic fibrosis. Davies has been involved with the UK CF Gene Therapy Consortium since it was established in 2002. She led the first trials of CFTR modulators in young children. She conducts bronchoscopic assays and electrophysiological measurements.

Davies leads the Strategic Research Centre for Pseudomonas Infection in Cystic Fibrosis at Imperial College London, one of few centres supported by the Cystic Fibrosis Trust. The centre looks to identify new ways to detect pseudomonas aeruginosa. Davies is part of the European CF Society Clinical Trials Network. She was involved in the design of the clinical trial, as well as validation of outcome measures. She works on the use of nasal potential difference to diagnose atypical cystic fibrosis. She was awarded a £2.8 million research grant from the Wellcome Trust to optimise the lentiviral vector for gene therapy.

In 2020 she won the Senior Investigator award from the National Institute for Health Research (NIHR).

Davies was elected a Fellow of the Academy of Medical Sciences in 2024.

Publications Davies publications include:

2011 An Atlas of Investigation and Management. Paediatric Respiratory Disease: Vol 1 Airways & Infection 2011 An Atlas of Investigation and Management. Paediatric Respiratory Disease: Vol 2 Parenchymal Disease